- Sarepta's FDA decision date; Flare gets Anna Protopapas as CEOPlus news about Deerfield, InflaRx, Praxis, Nuvectis, Pyxis Oncology, Vistagen, Arcutis Biotherapeutics and Nxera. 🔎 FDA to decide on future of Sarepta exon-skipping drugs by end of February: Th…Endpoints · 26d ago↗ source
- STAT+: All of Us tests a new approach to collect real-world data for researchThe NIH All of Us Research Program has secured thousands of electronic medical records through an innovative use of patient data-sharing networksSTAT · 26d ago↗ source
- STAT+: Investors double down on Bain-backed startupFDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech newsSTAT · 26d ago↗ source